Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methyldopa in severe pre-eclampsia
NCT01361425Phase 4Unknown
- Sponsor
- IMIP
- Start
- May 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in severe preeclampsia comparing Methyldopa with Placebo (2 arms). Primary endpoint: Arterial blood pressure stabilization at 1 week. Status: unknown.
02
Drugs
methyldopa
03
Conditions
severe preeclampsia
Beyond the preview
Go deeper on NCT01361425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01361425.